Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹138 Cr
P/E Ratio
269.38
P/B Ratio
2.31
Industry P/E
269.38
Debt to Equity
0
ROE
4.98 %
ROCE
7.19 %
Div. Yield
0.75 %
Book Value
28.79
EPS
0.24
CFO
₹40.89 Cr
EBITDA
₹43.33 Cr
Net Profit
₹13.63 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Lotus Eye Hosp
| -0.92 | 15.72 | -7.21 | 11.26 | 5.02 | 22.69 | 17.20 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Lotus Eye Hosp
| -20.90 | 8.95 | 47.50 | 50.87 | 43.51 | -21.22 | -11.92 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 65.60 | 67.52 | 79.91 | 7.95 | |
| 163.10 | 54.65 | 4.51 | 31.12 | |
| 14.84 | 21.98 | -- | -1.98 | |
| 54.65 | 23.31 | -- | -100.92 |
3 min read•By Research Desk
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser... cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping + AMG, suture, tatooing, tear suturing, and drop removal; pertygium, C3R, penetrating keratoplasty, TPK and DALK, and DASE; membrane peeling and endolaser; ERM removal, silicon oil and removal, vitrectomy lavage, FGE and C3F8, LPFC and CYCLO CRYO, and scleral buckling and belt buckle; ivta, avastin, razumab, ozurdex, zybev, eyelea, lucentis, and accentrix injections; trabeculectomy; and enucleation, evisceration, DCR and DCT, PTOSIS, and lateral tarsorrhaphy services. In addition, the company offers services in the areas of refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, uvea and ocular inflammation, zyoptix ultimate, and binocular vision. Further, it operates an eye bank, optical showroom, pharmacy, and research trust; and offers a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India. Read more
Incorporated
1997
Chairman
Kavetha Sundaramoorthy
Managing Director
Sangeetha Sundaramoorthy
Headquarters
Coimbatore, Tamil Nadu
Website
Looking for more details about Lotus Eye Hospital And Institute Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Lotus Eye Hospital And Institute Ltd stood at ₹ 70 Cr as on 31-Dec-24
The share price of Lotus Eye Hospital And Institute Ltd is ₹66.03 (NSE) and ₹66.45 (BSE) as of 17-Apr-2025 IST. Lotus Eye Hospital And Institute Ltd has given a return of 5.02% in the last 3 years.
Lotus Eye Hospital And Institute Ltd has a market capitalisation of ₹ 138 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Lotus Eye Hospital And Institute Ltd is 2.31 times as on 17-Apr-2025, a 0% premium to its peers’ median range of 2.31 times.
The P/E ratio of Lotus Eye Hospital And Institute Ltd is 269.38 times as on 17-Apr-2025, a 0% premium to its peers’ median range of 269.38 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Lotus Eye Hospital And Institute Ltd and enter the required number of quantities and click on buy to purchase the shares of Lotus Eye Hospital And Institute Ltd.
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping + AMG, suture, tatooing, tear suturing, and drop removal; pertygium, C3R, penetrating keratoplasty, TPK and DALK, and DASE; membrane peeling and endolaser; ERM removal, silicon oil and removal, vitrectomy lavage, FGE and C3F8, LPFC and CYCLO CRYO, and scleral buckling and belt buckle; ivta, avastin, razumab, ozurdex, zybev, eyelea, lucentis, and accentrix injections; trabeculectomy; and enucleation, evisceration, DCR and DCT, PTOSIS, and lateral tarsorrhaphy services. In addition, the company offers services in the areas of refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, uvea and ocular inflammation, zyoptix ultimate, and binocular vision. Further, it operates an eye bank, optical showroom, pharmacy, and research trust; and offers a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
The promoters of Lotus Eye Hospital And Institute Ltd are Sangeetha S and Kavetha Sundaramoorthy. They collectively own 37.73 per cent of the total equity. The chairman of the company is Kavetha Sundaramoorthy
There is no promoter pledging in Lotus Eye Hospital And Institute Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
65
|
|
|
55
|
|
|
22
|
|
|
20
|
| Lotus Eye Hospital And Institute Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
0.84
|
|
Operating margin(%)
|
-0.72
|
|
Net Margin(%)
|
1.02
|
|
Dividend yield(%)
|
0.75
|
Yes, TTM profit after tax of Lotus Eye Hospital And Institute Ltd was ₹1 Cr.
₹0.18
(
